The project "Precision Medicine Education for Clinical Implementation and Science Excellence in Medical Training" (PRECISEMED), is an Erasmus+ initiative aimed at enhancing medical education in Europe through updating medical curricula to include the latest developments in genetic testing.
2023-2-PL01-KA220-HED-000169812
ERASMUS+ KA220-HED - Cooperation partnerships in higher education
The project, spearheaded by the Medical University of Bialystok, with partners University College Cork and iBioScience Kft., focuses on integrating genomic knowledge to better prepare healthcare professionals for the increasing demands in the healthcare sector.
PRECISEMED will develop open-access, online curricula for genomic testing at both introductory and advanced levels. These curricula will be complemented by a Teacher's Guide to support medical educators with innovative, accessible, and effective educational resources. The project will implement these curricula through a newly developed Learning Management System (LMS), ensuring widespread availability and utility.
The expected outcomes include a two-tier teaching program enabling students to master genomic technologies, interpret results, and understand their clinical relevance, as well as the ethical, societal, and legal implications. This approach will employ innovative teaching methods like problem- and research-based learning to foster interdisciplinary education and better respond to job market needs.
The project spans three years, beginning April 2024 and concluding in March 2027, with a total budget of €250,000. The primary goal is to significantly improve the quality and relevance of medical training across Europe, contributing to the professional readiness of future medical personnel.
Objectives:
The PRECISEMED project strives to enhance the quality and relevance of medical education in Europe by updating the curricula of undergraduate and postgraduate medical programs to include the latest developments in genetic testing. This will enable future healthcare professionals to meet the growing demand for genomic knowledge in the healthcare sector. Moreover, the Teacher's Guide will equip medical teachers with innovative educational resources that are easily accessible and effective.
Implementation:
The PRECISEMED's partners will develop online, open-access curricula on genomic testing at introductory and advanced levels together with the Teacher's Guide. The quality-controlled curricula will be piloted at each partner university and made available as e-learning material on a self-developed Learning Management System (LMS) platform. Once completed, the education materials and the guide will be disseminated to the European HEIs and international networks through dedicated tools and events.
Results:
The developed two-tier teaching programme will enable students to master technologies, select next-generation sequencing tools, interpret results, understand the clinical relevance and grasp the ethical, societal, and legal implications of genomic testing and analysis. The programme will include innovative teaching and learning methods, like problem- and research-based learning as well as foster collaboration and interdisciplinary education, thus better responding to the needs of the job market.